Table 5.
Regression analyses.
| Relation | SOA | Overall model (Block 2) | R2 Change from Block 1 | Predictor | Beta | t | p |
|---|---|---|---|---|---|---|---|
| Compositional | 50 | R2 = 0.040, F(6, 1578) = 11.06, p < 0.001 | ΔR2 = 0.009, F = 5.19, p = 0.001 | Prime CD | −0.034 | −1.22 | 0.223 |
| Prime Ortho-N | −0.038 | −1.32 | 0.186 | ||||
| ELP Target zRT | 0.148 | 5.20 | <0.001 | ||||
| Co-occurrence | −0.055 | −1.47 | 0.141 | ||||
| Integ. Rating | −0.069 | −2.08 | <0.05 | ||||
| Visual Exp. Rating | 0.024 | 0.77 | 0.441 | ||||
| 300 | R2 = 0.066, F(6, 1149) = 13.51, p < 0.001 | ΔR2 = 0.039, F = 15.98, p < 0.001 | Prime CD | 0.013 | 0.43 | 0.670 | |
| Prime Ortho-N | −0.053 | −1.60 | 0.109 | ||||
| ELP Target zRT | .126 | 3.80 | <0.001 | ||||
| Co-occurrence | −0.102 | −2.37 | <0.05 | ||||
| Integ. Rating | −0.039 | −1.00 | 0.316 | ||||
| Visual Exp. Rating | −0.104 | −2.89 | <0.01 | ||||
| 800 | R2 = 0.032, F(6, 1378) = 7.68, p < 0.001 | ΔR2 = 0.008, F = 3.62, p = 0.01 | Prime CD | 0.037 | 1.27 | 0.200 | |
| Prime Ortho-N | −0.013 | −0.43 | 0.660 | ||||
| ELP Target zRT | 0.151 | 4.91 | <0.001 | ||||
| Co-occurrence | 0.007 | 0.19 | 0.850 | ||||
| Integ. Rating | −0.083 | −2.38 | <0.05 | ||||
| Visual Exp. Rating | −0.026 | −0.78 | 0.436 | ||||
| 1600 | R2 = 0.035, F(6, 1206) = 6.73, p < 0.001 | ΔR2 = 0.005, F = 2.16, p = 0.09 | Prime CD | −0.003 | −0.09 | 0.928 | |
| Prime Ortho-N | −0.012 | −0.38 | 0.708 | ||||
| ELP Target zRT | 0.169 | 5.16 | <0.001 | ||||
| Co-occurrence | −0.011 | −0.27 | 0.788 | ||||
| Integ. Rating | −0.058 | −1.53 | 0.127 | ||||
| Visual Exp. Rating | −0.018 | −0.52 | 0.605 | ||||
| Locative | 50 | R2 = 0.064, F(6, 1539) = 17.49, p < 0.001 | ΔR2 = 0.013, F = 7.18, p < 0.001 | Prime CD | −0.023 | −0.86 | 0.391 |
| Prime Ortho-N | 0.064 | 2.34 | <0.05 | ||||
| ELP Target zRT | 0.157 | 5.20 | <0.001 | ||||
| Co-occurrence | −0.090 | −3.10 | <0.01 | ||||
| Integ. Rating | −0.085 | −2.64 | <0.01 | ||||
| Visual Exp. Rating | 0.031 | 0.90 | 0.367 | ||||
| 300 | R2 = 0.050, F(6, 1124) = 9.87, p < 0.001 | ΔR2 = 0.009, F = 3.75, p = 0.01 | Prime CD | −0.046 | −1.42 | 0.155 | |
| Prime Ortho-N | 0.090 | 2.80 | <0.01 | ||||
| ELP Target zRT | 0.114 | 3.22 | <0.001 | ||||
| Co-occurrence | −0.077 | −2.26 | <0.05 | ||||
| Integ. Rating | −0.070 | −1.82 | 0.069 | ||||
| Visual Exp. Rating | 0.026 | 0.65 | 0.518 | ||||
| 800 | R2 = 0.032, F(6, 1343) = 7.29, p < 0.001 | ΔR2 = 0.018, F = 8.18, p < 0.001 | Prime CD | 0.058 | 1.96 | 0.050 | |
| Prime Ortho-N | 0.024 | 0.82 | 0.410 | ||||
| ELP Target zRT | 0.074 | 2.27 | <0.05 | ||||
| Co-occurrence | −0.107 | −3.40 | 0.001 |